Buck Wealth Strategies’s Jazz Pharmaceuticals JAZZ Stock Holding History

Buck Wealth Strategies’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.08M	Buy	8,635 +511	+6%	+$112K	0.22%	64
2026 Q1	$1.54M	Buy	8,124 +248	+3%	+$43.3K	0.19%	58
2025 Q4	$1.34M	Buy	7,876 +2,732	+53%	+$419K	0.17%	62
2025 Q3	$678K	Buy	+5,144	New	+$617K	0.09%	100
2023 Q4	–	Sell	-2	Closed	-$259	–	216
2023 Q3	$259	Hold	2	–	–	﹤0.01%	355
2023 Q2	$248	Hold	2	–	–	﹤0.01%	268
2023 Q1	$293	Buy	+2	New	+$296	﹤0.01%	198

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Buck Wealth Strategies's JAZZ Position: Q2 2026 in Review

Buck Wealth Strategies increased its Jazz Pharmaceuticals (JAZZ) stake by 6.3% in Q2 2026, buying an estimated $112K and bringing the position to 8,635 shares worth $2.08M. The position accounts for 0.22% of the portfolio, ranked #64.

Buck Wealth Strategies first reported a position in JAZZ in Q1 2023 and has held it in 7 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Buck Wealth Strategies held 8,635 shares of Jazz Pharmaceuticals worth $2.08M as of Q2 2026.
Buck Wealth Strategies bought 511 Jazz Pharmaceuticals shares in Q2 2026, an estimated $112K.
Jazz Pharmaceuticals made up 0.22% of Buck Wealth Strategies's portfolio in Q2 2026, its #64 holding.
Buck Wealth Strategies first reported a position in Jazz Pharmaceuticals in Q1 2023 and has held it in 7 quarters since.
641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.